SUNNYVALE, Calif. , Jan. 11, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Beverly A. Huss to the company's Board of Directors, effective January 7, 2018 . Ms. Huss also currently serves on the boards of Qool Therapeutics, Inc. , Surefire Medical, Inc.
UPPSALA, Sweden , and SUNNYVALE, Calif. , Oct. 4, 2021 /PRNewswire/ -- C-RAD AB (NASDAQ Stockholm: CRAD B) and Accuray Incorporated (NASDAQ: ARAY) announced today they have signed an agreement designed to enhance the Accuray Radixact ® System's ability to treat breast cancer.
The Léon-Bérard Center of Lyon, France, is now offering its cancer patients the benefits of Full Body Radiosurgery SUNNYVALE , Calif. , September 1, 2010 – Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that the first CyberKnife VSI
CARTI is First in Arkansas to Treat Patients with World's Only Robotic Radiosurgery System SUNNYVALE, Calif. , March 8, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the CARTI medical care team in Little Rock, Arkansas has treated the first patients in the state
SUNNYVALE, Calif. , Sept. 16, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced that, on September 11, 2019 , China's Customs Tariff Commission of the State Council issued a tariff exemption for medical linear accelerators. The tariff exemption, which will be effective September
SUNNYVALE, Calif. , Feb. 17, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced that class A user licenses for Accuray products were awarded to 16 hospitals during February by the Chinese National Health and Family Planning Commission (NHFPC).
CyberKnife Users' Meeting Highlights Clinical Studies and Emerging Trends in Brain, Lung and Prostate Radiosurgery SUNNYVALE, Calif ., Feb. 26 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced highlights from the clinical
Accuray to Host an Educational Symposium Highlighting Enhanced Capabilities of Its CyberKnife and TomoTherapy Treatment Systems SUNNYVALE, Calif. , July 29, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that more than 70 studies
Study Supports CyberKnife's Clinical Flexibility, Expanding Physicians Options for the Treatment of Prostate Cancer SUNNYVALE, Calif., April 8, 2008 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that a study published in
First System Purchased for Installation in Bangalore SUNNYVALE, Calif., Jan. 8 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Healthcare Global Enterprise (HCG) has purchased a CyberKnife(R) Robotic Radiosurgery
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
